Fresenius Medical Care AG & Co. KGaA (FMS) reported first-quarter 2024 adjusted earnings per share (EPS) of 36 cents, which beat the Zacks Consensus Estimate of 26 cents by 38.5%. The bottom line improved 28.6% year over year. Revenue Details Revenues of $5.13 billion (EUR 4,725 million) missed the Zacks Consensus Estimate by 0.3%. However, the company’s reported revenues were up 0.4 year over year and 2.5% at constant currency (cc). Segmental Details Fresenius Medical implemented a new operating model duri ...